Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar;55(3):e202451536.
doi: 10.1002/eji.202451536.

Two New Kindreds with Complete Factor D Deficiency

Affiliations
Case Reports

Two New Kindreds with Complete Factor D Deficiency

Mathilde Puel et al. Eur J Immunol. 2025 Mar.

Abstract

Inborn deficiencies of the alternative pathway (AP) of the complement system have been associated with life-threatening infections, mainly by encapsulated bacteria. Complete factor D (FD) deficiencies have been reported in only seven families in the literature. We report two new cases of biochemically and genetically confirmed complete FD deficiency, including the first in a Down syndrome patient. The index cases respectively suffered from severe H. influenza and N. meningitidis infections. Their FD activity was undetectable but was restored by adding recombinant human FD. FD levels were undetectable in the plasma of both patients using ELISA. Genetic analysis of the CFD gene identified a homozygous missense variant p.M40R in one patient, and compound heterozygous variants-a nonsense mutation p.Cys148* and a splice site variant c.212+2T>G-in the other. Patients with Down syndrome are more susceptible to infections, but this case highlights the importance of investigating the complement system, particularly the AP, even in those with Down syndrome or other secondary immune deficiencies. A familial study should follow if a congenital deficiency is found. The natural history of patients with inherited complete FD deficiency underscores the necessity of preventive measures against encapsulated bacteria for those receiving therapeutic MASP-3 or FD inhibitors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Familial and clinical descriptions of patients P1 and P2. (A) Genealogical tree of family A (patient P1); (B) genealogical tree of family B (patient P2); (C) necrotic lesions of P2.
FIGURE 2
FIGURE 2
Biochemical and genetical exploration of patients P1 and P2 complement factor D (CFD) deficiency. (A) Complement activity exploration and CFD dosage of P1, her parents, P2, and part of family B. (B) 3D representation of CFD protein with the two nonsense mutations found in P1 and P2 (red). Alpha helix are in blue and beta sheets in green. (C) CFD gene (NM_001928) with variants reported in the article (red) and in the literature (black).

References

    1. Merle N. S., Noe R., Halbwachs‐Mecarelli L., Fremeaux‐Bacchi V., and Roumenina L. T., “Complement System Part II: Role in Immunity,” Frontiers in immunology 6 (mai 2015): 257. - PMC - PubMed
    1. El Sissy C., Rosain J., Vieira‐Martins P., et al., “Clinical and Genetic Spectrum of a Large Cohort With Total and Sub‐Total,” Frontiers in Immunology 10 (Août 2019): 1936. - PMC - PubMed
    1. Sekine H., Machida T., Fujita T., and Factor D. Immunological Reviews 313, no. 1 (2023): 15‑24. - PubMed
    1. White R. T., Damm D., Hancock N., et al., “Human Adipsin is Identical to Complement Factor D and is Expressed at High Levels in Adipose Tissue,” Journal of Biological Chemistry 267, no. 13 (mai 1992): 9210‑3. - PubMed
    1. Kluin‐Nelemans H. C., van Velzen‐Blad H., van Helden H. P., and Daha M. R., “Functional Deficiency of Complement Factor D in a Monozygous Twin,” Clinical & Experimental Immunology 58, no. 3 (déc 1984): 724‑30. - PMC - PubMed

Publication types

Substances